Clinical Trial Update: A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of eltrombopag in Japanese patients with refractory, moderate or more severe aplastic anemia (completed; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cytopaenia | Phase 2 | Status: COMPLETED | Results posted: 2019-05-03